| 20.05.2025 13:25 | VAL | Holding(s) in Company | RNS |
| 12.05.2025 21:40 | VAL | IN BRIEF: ValiRx extends agreement with Dominion Biotech | Alliance |
| 12.05.2025 07:00 | VAL | Inaphaea Deal Extension With Dominion | RNS |
| 30.04.2025 07:00 | VAL | Commercial Update | RNS |
| 04.04.2025 18:29 | VAL, MET1, CORD | TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract | Alliance |
| 03.04.2025 07:00 | VAL | Termination of Letter of Intent with TheoremRx | RNS |
| 27.03.2025 07:00 | VAL | Directorate Changes and new Advisory Board | RNS |
| 21.03.2025 11:07 | VAL | Director Disclosure Update | RNS |
| 24.02.2025 16:20 | VAL | ValiRx shares fall as ends collaboration with Imperial College London | Alliance |
| 24.02.2025 07:00 | VAL | Conclusion of Evaluation Project | RNS |
| 03.02.2025 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
| 30.01.2025 07:00 | VAL | Extension of Evaluation Agreement | RNS |
| 29.01.2025 07:00 | VAL | New Evaluation and Option Agreement | RNS |
| 15.01.2025 12:47 | PEEL, VAL | Holding(s) in Company | RNS |
| 15.01.2025 11:29 | VAL | Holding(s) in Company | RNS |
| 14.01.2025 07:00 | VAL | Holding(s) in Company | RNS |
| 09.01.2025 11:37 | VAL | Holding(s) in Company | RNS |
| 09.01.2025 11:14 | VAL | Holding(s) in Company | RNS |
| 08.01.2025 07:00 | VAL | Holding(s) in Company | RNS |
| 02.01.2025 11:45 | VAL | Holding(s) in Company | RNS |
| 31.12.2024 13:06 | VAL | Holding(s) in Company | RNS |
| 31.12.2024 10:58 | SAR, VAL, ROSE | AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank | Alliance |
| 31.12.2024 10:58 | VAL | ValiRx extends TheoremRx exclusivity period to final May 31 deadline | Alliance |
| 31.12.2024 08:39 | VAL | Update on proposed sub-license of VAL201 | RNS |
| 30.12.2024 13:30 | VAL | Result of GM, Issue of Equity, Warrants and TVR | RNS |
| 20.12.2024 07:00 | VAL | ValiRx launches new interactive investor website | Reach |
| 22.11.2024 07:00 | VAL | Inaphaea award of HEIF Funding and PhD sponsorship | RNS |
| 20.11.2024 18:09 | VAL | IN BRIEF: ValiRx extends Ambrose Healthcare exclusivity agreement | Alliance |
| 20.11.2024 07:00 | VAL | Update on proposed sub-license of VAL401 | RNS |
| 19.11.2024 11:39 | VAL | ValiRX adds to streak of deals with cancer cell test materials win | Alliance |
| 19.11.2024 10:39 | WBI, VAL, LLAI | AIM WINNERS & LOSERS: Woodbois subscription raises over GBP1 million | Alliance |
| 18.11.2024 12:21 | VAL | IN BRIEF: ValiRx notes subsidiary's shipment of patient derived cells | Alliance |
| 30.10.2024 07:00 | VAL | Update on proposed sub-license of VAL201 | RNS |
| 18.10.2024 07:00 | VAL | Directorate Change | RNS |
| 14.10.2024 07:00 | VAL | Investor Webinar | RNS |
| 07.10.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
| 27.09.2024 13:56 | ROQ, KDNC, VAL | EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart | Alliance |
| 27.09.2024 07:00 | VAL | Half-year Report | RNS |
| 24.09.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
| 18.09.2024 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
| 16.09.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
| 09.09.2024 22:03 | PANR, UKOG, CIZ | TRADING UPDATES: Light Science Technologies wins two new contracts | Alliance |
| 09.09.2024 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
| 09.09.2024 07:00 | VAL | Investor Evening | RNS |
| 27.08.2024 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
| 12.08.2024 12:01 | FLTR, IGG, SBRY | EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx | Alliance |
| 12.08.2024 07:00 | VAL | Directorate Change | RNS |
